Chennai: In line with the mission to offer probably the most complete and superior most cancers care in India, Apollo Proton Cancer Centre (APCC) has launched the newest suite of cutting-edge cancer-fighting know-how referred to as Tomotherapy.

Kanimozhi Karunanidhi, Member of Parliament-Lok Sabha, Govt of India, inaugurated Tamil Nadu’s first RadiXactX9 Tomotherapy and India’s first excessive precession TMI/TMLI programme within the presence of Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd, Karan Puri, Chief Executive Officer, APCC, Dr Rakesh Jalali, Medical Director & HOD- Radiation Oncology, APCC, Dr Sapna Nangia, Senior Consultant – Radiation Oncology and Dr Srinivas Chilukuri, Senior Consultant Radiation Oncology, APCC.

APCC is now the primary in Tamil Nadu to supply RadiXactX9 Tomotherapy and India’s first High Precession TMI/TMLI programme, due to its Helical Tomotherapy know-how, which offers larger precision and management over radiation therapy supply whereas minimising harm to wholesome tissues. The each day imaging functionality makes it potential for clinicians to establish and proper any variations in affected person positioning, modifications within the tumour, or different components, equivalent to weight acquire or loss. As the Tomotherapy System’s precision reduces radiation publicity to surrounding wholesome tissues, sufferers expertise fewer unwanted effects than these receiving typical types of radiation remedy.

Karunanidhi mentioned, “Tamil Nadu has always been at the forefront of medical infrastructure and healthcare delivery in India, and I am proud to say that the launch of Tomotherapy at the Apollo Proton Cancer Centre is yet another example of this. With this new technology, the APCC is not only setting new standards for cancer care in Tamil Nadu but also in South Asia and the Middle East. I commend the APCC for its commitment to delivering the finest in proton and photon therapies, and for investing in the latest and most advanced technologies to enhance cancer care for patients.”

Reddy added, “The launch of Tomotherapy at the Apollo Proton Cancer Centre marks a momentous occasion that will redefine cancer treatment in South Asia. With the increasing prevalence of cancer in India, projected to grow seven-fold by 2025 due to various factors such as air pollution, smoking, and sedentary lifestyles, the introduction of this technology comes at a critical time.”

Dr Jalali emphasised the significance of the brand new know-how, saying “With Tomotherapy, we are able to offer our patients a high level of precision and accuracy in radiation therapy that was once thought impossible.”

Tomotherapy on the APCC underscores the centre’s dedication to providing probably the most superior and efficient cancer-fighting applied sciences in South Asia.